CHAPTER 1 : ABOUT THE NIRLIFE HEALTH CARE

Nirlife is the brand of the healthcare division of well-diversified FMCG Major- Nirma Limited.

Being in the healthcare domain Nirlife assumes great sense of responsibility and wholeheartedly

concentrates on better value delivery with uncompromising quality, guaranteed efficiency, and

continuous innovation.

1) HISTORY :

Established in 1969, Nirma has earned a strong presence in millions of households within as

well as beyond Indian frontiers. And today this name spells unparalleled growth and absolute

reliability, with a market leader position in one of the largest economy. Nirma keenly extends

this success story into the healthcare domain under Nirlife brand.

After all, health is happiness.

Nirlife Healthcare is one of the largest manufacturer and marketer of extensive range of

parenteral products and medical devices in the global market.

With a strong research oriented work culture, state-of-the-art production facility and end-to-

end product development capabilities - Nirlife is comfortably poised to establish itself as a

leading healthcare brand in the international and domestic market.

The manufacturing facility is WHO GMP, CE and ISO certified. The set-up is equipped with

quality systems and processes to adhere stringent evaluation parameters and to sustain growth

through innovation, R&D and state-of-art analytical infrastructure in healthcare segment.

Nirlife brand is established with a vision to attain significant presence in healthcare segment

globally through cost effectiveness, innovation and quality healthy life to the end-user...

1

Nirlife manufactures "Oneuse" range of

medical devices In a fully integrated and automated state-of-the-art Facility. This facility includes

compounding of plastic, moulding of components, assembling of components and packaging of

medical devices, all under one roof.

1.1) VISION, MISSION, BELIEF, VALUE :

Belief:

“Health is Happiness”   ……

Vision:

To be a leading player in the field of healthcare by manufacturing and supplying high quality

healthcare products and thus contribute to the well being of humankind and offering health and

thus Happiness.

Mission:

To provide high quality healthcare products to masses at affordable price.

Values:

Continuous exploration & development of new products & processes

Laying emphasis on cost effectiveness

Maintaining effective Quality Management System

Complying with safety, environment and social obligations

Imparting training to all involved on a continuous basis

Team work and active participation all around

2

1.2) EXPERTISE / OPERATIONS :

With four multi therapy divisions Nirlife is leading player in the Healthcare industry in

India.We are leader in Intravenous infusions, Parenteral Anti-infective, Small volume

parenterals and Medical disposable devices. In specialty therapy, like Anesthesia, Plasma

Expander, Total Parenteral Nutrition, Blood products, we are aiming to be a leader by 2011.

Under disposable medical devices, we at Nirlife have “Oneuse” range of disposables includes

syringe, needle, Infusion sets, Micro drip set, Alcoholic swab etc. We are enjoying 50% market

share in disposable devices.

We have forayed into manufacturing of pharmaceuticals in liquid, solid, powder, semi-solid

dosage forms as well as in novel drug delivery systems.

State of the art manufacturing facility

We have adopted state of the art technology and equipments from world majors. This gives us

edge over others in terms of our offering quality products to our valued customers.

We at Nirlife, believes in “Health is Happiness” and thus involved in providing quality

healthcare products to masses and thus offering helping hand to Medical professionals in their

noble cause of saving life and offering Health to mankind

Nirlife – a healthcare division of Nirma Limited acquired 20 years old manufacturing

facility.This is our 1st step in healthcare segment with parenteral preparation.

3

Today, Nirlife has large operational capabilities to produce and market over 250 million bottles of

Large Volume Parenteral, 1300 million ampoules of Small Volume Parenteral and 1500 million

units of Medical Devices - perhaps one of the largest capacities in the global marketplace. The

production base is located at Sachana village, in vicinity of Ahmedabad, Gujarat, India. Nirlife has

world class technology at Sachana near Viramgam, 55 km away from Ahmedabad.

At present Nirlife became market leader within a short span of 3 years and Nirlife became India’s

largest manufacturer in parenteral preparations and beat the giants through marketing Large

Volume Parenteral (LVP), Small Volume Parenteral (SVP), High-end Parenteral Nutrition

products, Medical Devices and consumer healthcare products.

1.3) PRODUCTS :

Mainly 4 category of product are there namely as:

MDD (medical disposable devices)

SVP (small volume parentaral)

CCD (critical care devices)

LVP (large volume parentaral)

PRODUCT 1 : MDD (medical disposable devices)

Oneuse Disposable Medical Devices

Sr. No.

Brand Name Product Name Volume/ Size / SKU Packing

1 Oneuse Syringe 2 pc syringe 2, 5, 10 ml Blister pack (100/ pack)

2 Oneuse Syringe 3 pc syringe 2, 3, 5 ml Ribbon pack (100/ pack)

3 Oneuse Needle Needle 18 G to 28 G Blister pack (100/ pack)

4

4Oneuse

Infusion setWith / Without

airventBlister / Ribbon pack (50/ pack)

5Oneuse

Alcoholic Swab

Alcohol swab Sachet (100 / pack)

6Oneuse Blood Transfer set

Blood Transfer set Ribbon pack (25/ pack)

7Oneuse Insulin

syringeInsulin syringe

30G , 31 G30G, 31 G Ribbon pack (10/ pack)

8Oneuse

Microdrip setMicro drip set Ribbon pack (25/ pack)

9Oneuse

Measured volume set

Measured volume set

Ribbon pack (10/ pack)

10Oneuse

Surgical glovesSurgical gloves 6.5', 7.0', 7.5'

11Oneuse Adult

DiperAdult diper

Medium, Large, Extra large

Plastic bag (5 / bag and 10/ bag)

PRODUCT 2 : SVP (small volume parentaral)

Anti-infective

Sr. No.Brand Name

Product Name Volume Container

1 Nircip Ciprofloxacin Injections 100 ml Nipple Head / Euro Head

2 Nirget Gatifloxacin Injections 200 ml Nipple Head / Euro Head

3 Nirliv Levofloxacin Injections 100 ml Nipple Head / Euro Head

4 Nirflox Ofloxacin Injections100 ml, 200

mlNipple Head / Euro Head

5 Nirmet Metronidazole Injections 100 ml Nipple Head / Euro Head

6 Nirzolid Linezolid Injections100 ml, 300

mlNipple Head / Euro Head

5

7 Nirmet plusMetronidazole with

Dextrose500 ml Nipple Head / Euro Head

8 Flucanir Fluconazole Injection 100 ml Glass bottle

Diluents

Respules

6

Sr. No.Brand Name

Product Name Volume Container

1 SWFISterile Water for

Injection5 , 10, 20

mlPlastic ampoule

2 NSSodium chloride

Injection5, 10 ml Plastic ampoule

3 30D 30% Dextrose 20 ml Plastic ampoule

4 50D 50% Dextrose 20 ml Plastic ampoule

Sr. No. Brand Name Product Name Volume Container

1 Salbutamol Salbutamol 2.5 ml Plastic ampoule

2 Levosalbutamol Levosalbutamol 2.5 ml Plastic ampoule

PRODUCT 3 : CCD (critical care devices)

specialty products

Sr. No. Brand Name Product Name Volume Container

1 Meronir Meropenem Injection 500 mg, 1 gm Glass vial

2 Iminir Imipenem Injection 500 mg Glass vial

3 Meronir kitMeropenem injection + NS 100 ml

+ IV set1 gm Glass vial

4 Iminir KitImipenem injection +NS 100 ml +

IV set500 mg Glass vial

5 Pipranir kitPipracillin + Tazobactum + NS 100

ml + IV Set4.5 gm Kit

6 Cefonir kitCefoperazone +Sulbactum + NS 100

ml+ IV set1 gm Kit

Anesthetic range of products

7

Plasma Volume Expander

Sr. No.

Brand Name Product Name Volume Container

1 Nirhes - 200Hydroxy Ethyl Starch

(200/0.5) - 6%500 ml Plastic bottle

2 Nirhes - 130Hydroxy Ethyl Starch

(130/0.4) - 6%500 ml Bag

3 Nirtran Dextran IV infusion 500 ml Plastic bottle

8

Sr. No. Brand Name Product Name Volume Container

1 NirfolPropofol Intravenous

Injection10, 20, 50, 100

mlGlass bottle

2 LignonirLignocaine injection

2%30 ml Glass vial

3 Lignonir ADRLignocaine Injection with Adrenaline 2%

30 ml Glass vial

4 KetanirKetamin Injection

(50 mg/ ml)10 ml Glass vial

5 Midanir Midazolam Injection 5 ml, 10 mlGlass amp,

Vial

6 Thionir Thiopentone sodium500 mg, 1000

mgGlass vial

7 StignirNeostigmine

Injection1 ml, 5 ml Ampoule

8 Atranir Atracurium injection 2.5, 5 , 10 ml Ampoule

9 VecurnirVecuronium

injection2, 10 mg Glass vial

10 RocunirRocuronium

injection5 ml Glass vial

 

Blood and related products

Sr. No.Brand Name

Product Name Volume Container

1 Eponir Erythropoietin injection2000 iu, 4000

iuPFS

2 IVIGIntravenous

Immunoglobulin G100 ml Glass bottle

3 Sucronir Iron Sucrose Injection 5 ml Glass ampoule

4 Hepanir Heparin Injection5000 iu, 25000

iuGlass vial

PRODUCT 4: LVP (large volume parentaral)

Dextrose containing products

9

Sr. No. Brand Name Product Name Volume Container

1 5D 5% Dextrose100 / 250 /

500 / 1000 mlNipple Head / Euro

Head/ Bag

2 10 D 10% Dextrose100 / 250 /

500 / 1000 mlNipple Head / Euro

Head/ Bag

3 20 D 20% Dextrose100 / 250 /

500 / 1000 mlNipple Head / Euro

Head/ Bag

4 25 D 25% Dextreose100 / 250 /

500 / 1000 mlNipple Head / Euro

Head/ Bag

5 50 D 50% Dextrose100 / 250 /

500 / 1000 mlNipple Head / Euro

Head/ Bag

Uretics

Sr. No. Brand Name Product Name Volume Container

1 20 M 20% Mannitol 100 ml, 350 ml Nipple Head / Euro Head

2 Nirtol GMannitol with

Glycerin100 ML Nipple Head / Euro Head

Dialysis solution

Other

Sr. No. Brand Name Product Name Volume Container

1 Fructonir10% Invert

Sugar500 ml

Nipple Head / Euro Head

2 Fructonir NSInvert Sugar

with NS500 ml

Nipple Head / Euro Head

10

Sr. No. Brand Name Product Name Volume Container

1 PD Peritoneal Dialysis solution 2 lit, 3 lit Bags

11

CHAPTER 2 : INTRODUCTION TO TOPIC

2.1) MARKET SHARE : Market share is one of the primary indicators companies use to measure

how well they are doing versus competitors. Market share is defined as … “ The percentage of

business or product or sales a company wields out of total business or product or sales by all

competitors combined in any given market respectively.”

The total available business is called market potential. There are two basic ways of stating market

share figures

1) Percent of Sales

2) Percent of Units

3) Questionnaire fill

2.1.1) PERCENT OF SALES : Percent of sales is one measure of market share. For example, if a

small electronics firm sells $2 million in a market with a total of $100 million in sales, its market

share is 2 percent. That is just one market, however. Imagine that the small electronics firm sells

products in 10 markets -- with market share figures varying between 1 percent and 4 percent in

each market. The firm's total market share for all 10 markets might be 2.5 percent.

2.1.2) PERCENT OF UNITS : Companies can calculate market share using sales units. For

example, a small bottled-water distributor may sell 10,000 units per year out of the 100,000 sold in

a local market area by all competitors combined. Therefore, its market share is 10 percent for that

market. Unit market share may be more useful in some cases, as companies can better derive

average product prices of competitors. They can use this information to better price their own

products.

12

2.1.3) QUESTIONNAIRE FILL : Questionnaire fill up, which is used most often by researchers,

is based on a series of competitive interviews and/or question where each respondent is asked for

certine question related to product and/or business and from that market share would be

determined.

2.2) MDD PRODUCTS OF NIRLIFE HEALTH CARE : MDD means medical disposable

devices. It includes

1) Syringe and Needle

3) IV set

4) Diper

2.2.1) SYRINGE AND NEEDLE : A syringe is a simple pump consisting of a plunger that fits

tightly in a tube. The plunger can be pulled and pushed along inside a cylindrical tube (called a

barrel), allowing the syringe to take in and expel a liquid or gas through an orifice at the open end

of the tube. The open end of the syringe may be fitted with a hypodermic needle.

TABLE 2.2.1.1) A DIAGRAM OF SYRINGE

13

CHART 2.2.1.1) A DIAGRAM OF NEEDLE SHAPES

TABLE 2.2.1.2) COLOUR WITH SIZE OF NEEDLE

14

VARIABLE THAT AFFECT SYRINGE AND NEEDLE’S MARKET SHARE :

Quality of gradution mark

Tranaparency of barrel

Smoothness of pluger

Leakage

Gasket material

Size availability

Price

Needle bevel availability

Colour availability

Pain

Gauge size availability

2.2.2) IV SET : it is intravenous set mainly used for  the  continuous  introduction  of  a  solution

intravenously , a drop at a time. venous means vein and Intravenous (IV) medications are a

solutions administered directly into the venous circulation via a syringe or intravenous catheter

(tube). The device used to administer an intravenous solution, such as the familiar IV drip.

IV CATHETER : Intravenous catheters are used for administration of medication and fluids

directly into your veins.   They are usually located in your hand, arm, or neck. It contains a small

needle with a hollow tube inserted into a vein and used to give medicines or fluids. It refers to the

placement of a small, flexible, tubular instrument that is passed into a vein (typically in the

forelimb) and secured there to provide a port that allows delivery of fluids, nutrition, or blood

products directly into the bloodstream.

15

VARIABLE THAT AFFECT IV SET’S MARKET SHARE :

Price

Quality of material

Tip

Traperancy of tube

DIAGRAM OF IV SET AND IV CATHETER

16

TABLE 2.2.2.1) CATHETER WITH COLOUR AND SIZE

2.23) ADULT DIAPER : An adult diaper (or adult nappy) is a diaper made to be worn by a

person with a body larger than that of an infant or toddler. Diapers can be necessary for adults with

various conditions, such as incontinence, mobility impairment, severe diarrhea or dementia. Adult

diapers are made in various forms, including those resembling traditional child

diapers, underpants, and pads resemblingsanitary napkins (known as incontinence pads).

17

VARIABLE THAT AFFECT DIAPER’S MARKET SHARE :

Price

Material

Elasticity

Comfortness

Size availability

18

CHAPTER 3 : LITERATURE REVIEW

3.1) According to study conducted by An IndiaCLEN Programme Evaluation Network Study

(IPEN Study) on “Assessment of injection practices in India” in partnership with Ministry of

Health and Family Welfare, Government Of India, World bank , Medical injections

administered in India per year add up to 4.5 billion (the approximate annual demand in Indian

market) . Aggregate demand of syringes in the states Gujarat, Maharashtra, Andhra Pradesh,

Karnataka and Tamilnadu account for around 45% of total annual demand in India. 62% i.e. 3.1

billionof these injections are unsafe. In India around 0.3 million people die each year because of

being administered unsafe injections (according to World Health Organisation, WHO).

3.2) According to Netscribes (India) Pvt. Ltd and Dublin Research and Market  has announced

"Syringes And Needles Market in India 2011" report , as Growing Insulin and Vaccine Needs

Driving the Syringes & Needles Market in India, finds Netscribes The Indian syringes & needles

market is growing steadily owing to the better healthcare facilities arising from the improved

infrastructure. An analysis of the drivers explains the factors leading to the growth of the market

which include increasing need of insulin doses, increasing demand for vaccines, improving health

infrastructure, growing incidence of diseases, changing demographics and health check-up

packages. Some of the major challenges to the market are illegal recycling of syringes & needles

and problems associated with usage.

19

CHAPTER 4 : RESERCH METHODOLOGY

4.1) THE RESEARCH PROCESS : The Marketing research process involves a number

of interrelated activities which don’t rigidly follow a particular sequence. Followings are the

various steps in the research methodology process: 

1) Formulating the research problem.

2) Choice of research design.

3) Determining sources of data.

4) Designing data collection forms.

5) Determining sampling design and sampling size.

6) Organizing and conducting the field survey.

7) Processing and analyzing the collected data.

8) Preparing the research report.

4.2) NEED FOR THE STUDY:

Nirlife healthcare wants to know the market share and market presence of MDD products so

that whether they increase sales or not.

Nirlife healthcare wants to know the local and branded leader in the market of syringe and

needle, iv set and diaper

20

4.3) RESERCH TOPIC : “ In-depth study of market share and market presence of MDD

product with reference to nirlife health care pvt ltd. ”

4.4) RESERCH OBJECTIVE :

1) To find out MDD product’s market share and market presence of Nirlife health care pvt ltd.

2) To find out different Syringe and Needle, iv set, Diaper available in the market.

3) To identify variable that affect the market share of MDD product of Nirlife health care pvt ltd.

4.5) RESERCH QUESTION :

1) How to measure the market share market presence of Nirlife health care pvt ltd?

2) What are the different Syringe and Needle, iv set, Diaper available in the market?

3) What are the different variable that affect market share of MDD product of Nirlife health

care pvt ltd?

4.6) HYPOTHESIS :

H0 : There is association between preference of Syringe/Needle and consumption of

Syringe/Needle.

H1 : There is association between preference of IV set and consumption of IV set.

H2 : There is association between preference of Diaper and consumption of Diaper.

H3: There is association between preference of syringe/Needle and consumption of syringe/Needle.

21

4.7) RESEARCH DESIGN : It is a frame work or blue print for conducting the marketing

research project. It is a frame it specifies the details of the procedures necessary for obtaining the

information needed to structure and solve marketing research problems.

A research design lays the foundation for conducting the project. A good research design will

ensure that the marketing research project is conducted effectively and efficiently. Typically a

research design involves the following tasks:

1) Design exploratory, conclusive and or descriptive phase of the project.

2) Define the information needed.

3) Specify the measurement and scaling procedure.

4) Construct and present an appropriate form of data collection.

5) Specify the sampling process and sample size.

6) Develop a plan for data analysis.

The research design was conducted in two phases.

1) Exploratory Research

2) Conclusive Research

4.7.1) Exploratory Research : It is a type of research design, which has its primary objective of

getting an insight into and understanding of the problem situation confronting the researcher.

It has been conducted using secondary data & qualitative research.

Secondary data:

1. External:

Published material

Computerized database

22

4.7.2) Conclusive Research :

Descriptive research : It is a type of conclusive research that has its major objective the

description of something usually market characteristics or functions.

Descriptive research is preplanned and structured. It is based on large amount of representative

samples.

For the descriptive research I have used the survey method in which single cross sectional

design has been adopted.

1) Survey method

Cross sectional design

single cross sectional

Single cross sectional : It is a cross sectional design in which one sample of respondents is

drawn from the target population and information is obtained from this sample only once.

Data Sources :

Primary Source: Questionnaire is a structured technique for data collection that consists of a

series of questions, written or verbal, that a respondent answers.

Research Instrument : A questionnaire is used as a data collection instrument for collecting

the Primary data. A questionnaire consists of various questions in a structured format.

23

4.7.3) POPULATION DEFINITION :

Population : All the customers such as medical stores and pathology labs.

Sampling element :All the customers in ahmedabad such as medical stores and pathology

labs

Sampling unit : A customer such as medical stores and path lab

Sampling frame : Not available

Extent : In Ahmedabad.

Time : May to June 2013

Non probability

sampling technique : Judgemental sampling

Sample size : Likert scale: 5-1/6=0.67

N = z2*62/D2

Z = 1.96

6 = 0.67

E = 0.138

N= (1.96)2*(0.67)2/ (0.138)2

N=90 

Data analysis technique : Frequency Analysis

Data analysis software : SPSS and Microsoft Excel.

Significance level : 0.05 (95% confidence level is used where rejection rate is 5%)

24

CHAPTER 5 : DATA ANALYSIS

DATA ANALYSIS 1 : 5.1) For retail stores

1) Which company’s syringe and needle you are keeping ?

NAME RESPONSE PERCENTAGE

Bd 41 41 %

Nirlife health care 33 33 %

Dispo 21 21 %

Tiger get 15 15 %

Bd Nirlife health care Dispo Tiger get0

5

10

15

20

25

30

35

40

4541

33

21

15

MARKET PRESENCE

25

TABLE-5.1.1

CHART-5.1.1

Interpretation:

There are 4 branded company’s syringe and needle available in the market BD , NIRLIFE

HEALTH CARE, DISPOVAN, TIGER GET .

The market presence of BD is 37% , NIRLIFE HC is 30% , DISPOVAN is 19% , TIGER

GET is 14% .

26

2) Why are you keeping that syringe and needle ?

NAME VARIABLE RESPONSE PERCENTAGE

Bd

Bd_quality 19 19 %

Bd_doctor’s prescribe 10 10 %

Bd_Material 10 10 %

Bd_Services 02 02 %

Nirlife health care

Nl_Quality 10 10 %

Nl_Price 17 17 %

Nl_Material 5 5 %

Nl_Services 1 1 %

Dispo

D_Quality 8 8 %

D_Price 6 6 %

D_Material 4 4 %

D_Services 1 1 %

Tiger get

Tg_Quality 4 4 %

Tg_Price 5 5 %

Tg_Material 3 3 %

Tg_Services 3 3 %

27

TABLE-5.1.2

Bd_quality

Bd_doctor’s

pre

scrib

e

Bd_Mate

rial

Bd_Service

s

Nl_Quali

ty

Nl_Pric

e

Nl_M

ateria

l

Nl_Ser

vices

D_Quality

D_Price

D_Mate

rial

D_Service

s

Tg_Quality

Tg_Price

Tg_Mate

rial

Tg_Service

s0

2

4

6

8

10

12

14

16

18

20 19

10 10

2

10

17

5

1

8

6

4

1

45

3 3

EFFECTIVE VARIABLE

Interpretation:

BD’s market presence is due to quality and is 19% , NIRLIFE HC’s market presence is 17%

and it is due to its low price and greater margin to retail stores , DISPOVAN’s market presence

is 8% due to quality and TIGERGET’s market presence is average in all criteria.

In market BD is well known for its quality , NIRLIFE HC is known for its good margin and

DISPOVAN is known for its quality and low price.

28

CHART-5.1.2

3) Which company’s IVset you are keeping ?

NAME RESPONSE PERCENTAGE

B braun 38 38 %

Nirlife health care 33 33 %

Bd 29 29 %

B braun Nirlife health care Bd 0

5

10

15

20

25

30

35

40 38

33

29

MARKET PRESENCE OF IV SET

Interpretation:

There are 3 company’s iv set available in the market B BRAUN, NIRLIFE HC, BD.

The market presence of B BRAUN is 38%, NIRLIFE HC is 33% and BD is 29% in iv set in

retail stores.

4) Which company’s diapers you are keeping ?

29

TABLE-5.1.3

CHART-5.1.3

NAME RESPONSE PERCENTAGE

Sumo 25 25 %

Nirlife health care 14 14 %

Teddy baby 14 14 %

Friends 16 16 %

Puppy 09 09 %

P/g 20 20 %

Sumo Nirlife health care

Teddy baby Friends Puppy P/g 0

5

10

15

20

25

30

25

14 1416

9

20

MARKET PRESENCE OF DIAPER

Interpretation:

There are 6 company’s adult diaper available in the market SUMO, NIRLIFE HC, TEDDY

BABY, FRIENDS, PUPPY, P/G.

There are 25% retail stores are keeping adult diaper of SUMO, 14% of NIRLIFE HC, 14% of

TEDDY BABY, 16% of FRIENDS, 9% of PUPPY and 20% of P/G.

30

TABLE-5.1.4

CHART-5.1.4

5) What do u think about consumption per month for syringes and needles ?

a) Less than 20 b) 21-40 c) 41-60 d) Above 60

NAME VARIABLE RESPONSE PERCENTAGE

Bd

Bd_Less than 20 5 5 %

Bd_21-40 10 10 %

Bd_41-60 16 16 %

Bd_Above 60 10 10 %

Nirlife healthcare

Nl_Less than 20 2 2 %

Nl_21-40 6 6 %

Nl_41-60 8 8 %

Nl_Above 60 17 17 %

Dispo

D_Less than 20 6 6 %

D_21-40 9 9 %

D_41-60 6 6 %

D_Above 60 0 0 %

Tiger get

Tg_Less than 20 4 4 %

Tg_21-40 4 4 %

Tg_41-60 4 4 %

Tg_Above 60 3 3 %

31

TABLE-5.1.5

CHART-5.1.5

Bd_Less t

han 2

0

Bd_21-40

Bd_41-60

Bd_Above 60

Nl_Les

s than

20

Nl_21-4

0

Nl_41-6

0

Nl_Above 6

0

D_Less t

han 2

0

D_21-40

D_41-60

D_Above 60

Tg_Less t

han 2

0

Tg_21-40

Tg_41-60

Tg_Above 60

0

2

4

6

8

10

12

14

16

18

5

10

16

10

2

6

8

17

6

9

6

0

4 4 43

CONSUMPTION

Interpretation:

The BD’s syringe and needle is selling highest in 41-60 quantity and is 16%, NIRLIFE HC is

selling highest in >60 quantity and is 17%, DISPO is selling in 21-40 quantity is 9% and TG

is selling average in all quantity.

6) what do u think about consumption per month for IV set ?32

a) Less than 20 b) 21-40 c) 41-60 d) Above 60

NAME VARIABLE RESPONSE PERCENTAGE

B braun

Bb_less than 20 4 4 %

Bb_21-40 16 16 %

Bb_41-60 17 17 %

Bb_Above 60 3 3 %

Nirlife health care

Nl_Less than 20 4 4 %

Nl_21-40 7 7 %

Nl_41-60 12 12 %

Nl_Above 60 10 10 %

Bd

Bd_Less than 20 3 3 %

Bd_21-40 6 6 %

Bd_41-60 12 12 %

Bd_Above 60 8 8 %

0%

2%

4%

6%

8%

10%

12%

14%

16%

18%

4%

16%17%

3%4%

7%

12%

10%

3%

6%

12%

8%

CONSUMPTION OF IV SET

33

TABLE-5.1.6

CHART-5.1.6

Interpretation:

B BRAUN is selling highest in 41-60 quantity and is 17%, NIRLIFE HC is selling highest

12% in 41-60 % and BD is selling highest 12% in 41-60 quantity in retail stores

7) What do u think about consumption per month for diaper ?34

a) Less than 20 b) 21-40 c) 41-60 d) Above 60

NAME VARIABLE RESPONSE PERCENTAGE

Sumo

s_Less than 20 2 2 %

S_21-40 5 5 %

S_41-60 8 8 %

S_Above 60 10 10 %

Nirlife healthcare

Nl_Less than 20 2 2 %

Nl_21-40 5 5 %

Nl_41-60 5 5 %

Nl_Above 60 2 2 %

Teddy baby

Tb_Less than 20 1 1 %

Tb_21-40 6 6 %

Tb_41-60 4 4 %

Tb_Above 60 3 3 %

Friends

Fs_Less than 20 4 4 %

Fs_21-40 5 5 %

Fs_41-60 3 3 %

Fs_Above 60 4 4 %

Puppy

Pp_Less than 20 1 1 %

Pp_21-40 3 3 %

Pp_41-60 4 4 %

Pp_Above 60 1 1 %

p/g

Pg_Less than 20 3 3 %

Pg_21-40 4 4 %

Pg_41-60 6 6 %

Pg_Above 60 7 7 %

35

TABLE-5.1.7

CHART-5.1.7

S_less

than 2

0

S_41-

60

Nl_Les

s tha

n 20

Nl_41-

60

Tb_Les

s tha

n 20

Tb_41

-60

Fs_Les

s tha

n 20

Fs_41

-60

Pp_Les

s tha

n 20

Pp_41

-60

Pg_Les

s tha

n 20

Pg_41

-60

0

2

4

6

8

10

12

2

5

8

10

2

5 5

2

1

6

4

3

4

5

3

4

1

3

4

1

3

4

6

7

CONSUMPTION OF DIAPER

Interpretation:

The SUMO is selling highest in >60 quantity and is 10%, NIRLIFE HC is selling highest in

21-40 and 41-60 quantity and is 5%, TEDDYBABY is selling highest as 6% in 21-40 quantity,

FRIENDS is selling highest as 5% in 21-40 quantity, PUPPY is selling highest as 4% in 41-60

quantity and P/G is selling highest in >60 quantity and is 7% in retail stores.

5.2) For path lab

36

1) Which company’s syringe and needle you preffered ?

NAME RESPONSE PERCENTAGEBd 28 28 %Nirlife health care 48 48 %Dispo 14 14 %Tiger get 10 10 %

Bd Nirlife health care Dispo Tiger get0

10

20

30

40

50

60

28

48

1410

MARKET PRESENCE

Interpretation:

There are 4 branded company’s syringe and needle available in the market BD , NIRLIFE

HEALTH CARE, DISPOVAN, TIGER GET in pathology lab.

The market presence of BD is 28 , NIRLIFE HC is 48% , DISPOVAN is 14% , TIGER GET

is 10%.

2) Why you preffered that syringe and needle ?

37

TABLE-5.2.1

CHART-5.2.1

TABLE-5.2.2

NAME VARIABLE RESPONSE PERCENTAGE

Bd

Bd_quality 12 12 %

Bd_doctor’s prescribe 6 6 %

Bd_Material 5 5 %

Bd_Services 5 5 %

Nirlife health care

Nl_Quality 10 10 %

Nl_Price 21 21 %

Nl_Material 8 8 %

Nl_Services 9 9 %

Dispo

D_Quality 5 5 %

D_Price 4 4 %

D_Material 4 4 %

D_Services 1 1 %

Tiger get Tg_Quality 1 1 %

Tg_Price 3 3 %

Tg_Material 5 5 %

Tg_Services 1 1 %

38

CHART-5.2.2

Bd_quality

Bd_doctor’s

pre

scrib

e

Bd_Mate

rial

Bd_Service

s

Nl_Quali

ty

Nl_Pric

e

Nl_M

ateria

l

Nl_Ser

vices

D_Quality

D_Price

D_Mate

rial

D_Service

s

Tg_Quality

Tg_Price

Tg_Mate

rial

Tg_Service

s0

5

10

15

20

25

12

6 5 5

10

21

8 9

5 4 4

1 13

5

1

EFFECTIVE VARIABLE

Interpretation:

BD’s market presence is due to quality and is 12% , NIRLIFE HC’s market presence is 21%

and it is due to its low price and greater margin to Pathology lab , DISPOVAN’s market

presence is 5% due to quality and TIGERGET’s market presence is average in all criteria.

In market BD is well known for its quality , NIRLIFE HC is known for its good margin and

DISPOVAN is known for its quality and low price.

3) What do u think about consumption per month ?

39

a) Less than 20 b) 21-40 c) 41-60 d) Above 60

NAME VARIABLE RESPONSE PERCENTAGE

Bd

Bd_less than 20 05 05 %

Bd_21-40 12 12 %

Bd_41-60 17 17 %

Bd_Above 60 04 04 %

Nirlife health care

Nl_Less than 20 6 6 %

Nl_21-40 14 14 %

Nl_41-60 20 20 %

Nl_Above 60 04 04 %

Dispo

D_Less than 20 3 3 %

D_21-40 5 5 %

D_41-60 4 4 %

D_Above 60 2 2 %

Tiger get

Tg_Less than 20 1 1 %

Tg_21-40 4 4 %

Tg_41-60 4 4 %

Tg_Above 60 1 1 %

40

TABLE-5.2.3

CHART-5.2.3

Bd_Less t

han 2

0

Bd_21-40

Bd_41-60

Bd_Above 60

Nl_Les

s than

20

Nl_21-4

0

Nl_41-6

0

Nl_Above 6

0

D_Less t

han 2

0

D_21-40

D_41-60

D_Above 60

Tg_Less t

han 2

0

Tg_21-40

Tg_41-60

Tg_Above 60

0

5

10

15

20

25

5

12

17

4

6

14

20

43

54

21

4 4

1

CONSUMPTION

Interpretation:

The BD’s syringe and needle is selling highest in 41-60 quantity and is 17%, NIRLIFE HC is

selling highest in 41-60 quantity and is 20%, DISPO is selling in 21-40 quantity is 5% and TG

is selling average in all quantity.

4) Which ml and type of syringes you preffered ?

41

Ml_______ and 2 pc

3 pc

NAME RESPONSE PERCENTAGE NAME RESPONSE PERCENTAGE2 ml 20 20 % 2 pc 46 46 %5 ml 54 54 % 3 pc 54 54 %10 ml 22 22 %20 ml 4 04 %

5 ml 10 ml 20 ml0

10

20

30

40

50

60

20

54

22

4

Interpretation:

For the preference , 20% Pathology lab prefer 2 ml, 54% Pathology lab prefere 5 ml, 22%

pathlab prefere 10 ml, 4% Pathology lab prefere 20 ml of syringe and needle .

42

TABLE-5.2.4

CHART-5.2.4

CHART-5.2.5

2 pc 3 pc 42

44

46

48

50

52

54

56

46

54

PREFERENCE

Interpretation:

For the preference, 54% Pathology lab prefer 3 pc and 46% Pathology lab prefer 2 pc syringe

and needle. So syringe and needle contain rubber gasket is widely used in pathology lab.

DATA ANALYSIS 2: 5.3) MICROSOFT EXCEL

43

TABLE-5.3.1.1

RATAIL STORES

Name of RS S/N Sales Iv set Sales Diaper Sales

Sanjay Medical Stores

DISPO 41-60 NL >60 SUMO 20<

Anand Medical Stores

DISPO 21-40 NL >60 SUMO 21-40

Sunrice Chemist NL >60 NL 41-60 FRIENDS 20<

Om Medical Stores bd 41-60B BRAUN

21-40 FRIENDS 21-40

Shayam Pharmacy BD 21-40B BRAUN

41-60 TEDDYBABY 20<

Sarthak Medical Stores

TG >60 NL 21-40 SUMO 21-40

Paras Ayurvedic Stores

TG 41-60 NL >60 SUMO 20<

Silver Medicines TG 21-40 NL 41-60 PUPPY 20<

Shanti Medical Stores

dispo >60 BD 21-40 P/G 21-40

Zalak Medivcal Stores

DISPO 41-60 BD >60 P/G 20<

Banshari Medical Stores

NL 21-40B BRAUN

41-60 NL 21-40

Paras Medical Stores

NL >60B BRAUN

21-40 FRIENDS 20<

Raj Chemist NL 41-60B BRAUN

>60 SUMO 21-40

Medilink Medical Stores

NL 21-40B BRAUN

41-60 friends 20<

Apollo Pharmacy NL >60B BRAUN

21-40 TEDDYBABY 21-40

Yash Stores DISPO 41-60 BD >60 NL 20<

Vijay Stores TG 21-40 NL 41-60 sumo 21-40

Manan Stores TG >60 NL 21-40 NL 20<

Prakash Ayurvedic Stores

DISPO 41-60 NL >60 TEDDYBABY 21-40

Paras Pharmacy DISPO/NL 21-40 NL 41-60 FRIENDS 20<

44

Gayatri Medical Stores

BD >60B BRAUN

21-40 P/G 21-40

Shreeji Medical Stores

BD 41-60B BRAUN

>60 P/G 20<

Arpan Chemists BD 21-40B BRAUN

41-60 P/G 21-40

Drashti Clinic BD >60B BRAUN

21-40 P/G 20<

Mudra Medicines NL 41-60B BRAUN

>60 P/G 21-40

Tapan Medical Stores

BD 21-40B BRAUN

41-60 P/G 20<

Jalaram Medical Stores

NL >60 NL 21-40 SUMO 21-40

Natraj Medical Stores

TG 41-60 NL >60 SUMO 20<

Karishna Medical Stores

DISPO 21-40 NL 41-60 SUMO 21-40

Maruti Medical Stores

TG >60 NL 21-40 SUMO 20<

Dhara Medical Stores

NL 41-60 NL >60 SUMO 21-40

Sagar Medical Stores

DISPO 21-40 NL 41-60 SUMO 20<

Mahavir Medical Stores

TG >60 BD 21-40 PUPPY 21-40

Umiya Medical Stores

NL 41-60 NL >60 NL 20<

Patel Medical Stores

DISPO 21-40 NL 41-60 PUPPY 21-40

Dev Medical Stores NL >60 NL 21-40 TEDDYBABY 20<

Ghanshayam Medical Stores

NL 41-60 NL >60 TEDDYBABY 21-40

Mahavir Medical Stores

BD 21-40B BRAUN

41-60 P/G 20<

Anuradha Medical Stores

BD >60 NL 21-40 FRIENDS 21-40

Chirag Medical Stores

NL 41-60 NL >60 TEDDYBABY 20<

45

Nirmal Medical Stores

BD 21-40B BRAUN

41-60 NL 21-40

Kuldeep Medical Stores

BD >60 BD 21-40 P/G 20<

Rajdeep Stores NL 41-60 BD >60 P/G 21-40

Karnavati Medical Stores

DISPO 21-40 BD 41-60 P/G 20<

Jagdish Medical Stores

BD >60 BD 21-40 P/G 21-40

Pated Medical Stores

DISPO 41-60 BD >60 P/G 20<

Parth Chemist BD 21-40 BD 41-60 P/G 21-40

Jalaram Medicine BD >60 BD 21-40 P/G 20<

Navdeep Medical Stores

NL 21-40B BRAUN

41-60 PUPPY 21-40

Narayan Medical Stores

TG 41-60 NL >60 FRIENDS 20<

Rajasthan Medical Stores

BD 21-40 BD 21-40 P/G 21-40

Radhe Medical Stores

BD >60 BD 41-60 P/G 20<

Hiren Drugist NL 41-60B BRAUN

21-40 P/G 21-40

Abhinav Pharma BD >60 BD 41-60 SUMO 20<

A One Medical Stores

TG 41-60 BD 21-40 P/G 21-40

Hardik Medical Stores

DISPO 21-40 BD >60 P/G 20<

Shree Ganesh Medical Stores

TD >60 BD 41-60 TEDDYBABY 21-40

Raj Medical NL 41-60 BD 20< FRIENDS 20<

Saurashtra Medical Stores

TG 41-60 BD 21-40 FRIENDS 21-40

Mahavir Medical Stores

DISPO >60 BD 41-60 PUPPY 20<

Sagar Medical Stores

BD 41-60 BD 21-40 TEDDYBABY 21-40

Karishna Chemist BD 21-40 NL >60 FRIENDS 20<

46

Darshan Drugist NL/DISPO >60B BRAUN

41-60 NL 21-40

Priyank Medical Stores

NL 41-60 NL 21-40 SUMO 20<

Kakdiya Medical Stores

NL 21-40B BRAUN

>60 TEDDYBABY 21-40

Yash Medical Stores

NL >60 BD 41-60 PUPPY 20<

Param Chemist BD 41-60 BD >60 FRIENDS 21-40

Kaham Medical Stores

BD >60B BRAUN

21-40 NL >60

Aum Pharmacy DISPO 21-40B BRAUN

21-40 PUPPY 21-40

Unjha Pharmacy NL >60 NL 41-60 SUMO 20<

Dwarkesh Chemist BD/NL 41-60B BRAUN

21-40 FRIENDS 21-40

Shreeji Medical Stores

NL >60 NL 41-60 SUMO 21-40

Abc Medicines BD >60B BRAUN

21-40 NL 21-40

Dhyani Stores NL >60 NL 41-60 PUPPY 20<

Sagar Stores BD >60B BRAUN

21-40 SUMO 20<

Akshar BD 41-60 NL >60 SUMO 20<

Simandhar Medical Stores

BD >60B BRAUN

>60 TEDDYBABY 21-40

Mahakali Medicines

BD 41-60 NL 21-40 SUMO 20<

Nirman Medicines NL >60B BRAUN

>60 FRIENDS 21-40

Shyam Medical NL 21-40B BRAUN

20< SUMO 20<

Gaurav Medicines BD 41-60 BD >60 P/G 20<

Navjyot Medical Stores

NL 21-40 BD 41-60 P/G 21-40

Rajdeep Medical Stores

BD >60 BD 21-40 P/G 20<

Nirmman Medical Stores

NL 21-40B BRAUN

41-60 PUPPY 21-40

47

Ram Chemist TG 41-60 NL >60 FRIENDS 20<

Janak Medical Stores

BD 41-60 BD >60 FRIENDS 21-40

Dhanvantari Medical Stores

NL >60B BRAUN

21-40 NL >60

Ghanshayam Medical Stores

DISPO 21-40B BRAUN

21-40 PUPPY 21-40

Drashti Medical Stores

NL >60 BD 41-60 SUMO 20<

Paras pharmacy BD 41-60B BRAUN

21-40 FRIENDS 21-40

Calculation:

Syringe – Needle Iv set Diaper

SUM OF LOW HIGH SUM OFLOW HIGH SUM OF LOW HIGH

ALL 3797 4800 ALL 3521 4680 ALL 1924 2760

NL 1378 1720 NL 1358 1700 NL 264 340

AVRG FLOW 42 54

AVRG FLOW 39 52

AVRG FLOW 21 31

NL % 36 35 NL % 39 36 NL % 14 12

Interpretation:

From the calculation of excel data sheet , the market share of NIRLIFE HC is found to be

35.5 % in syringe and needle in retail stores.

From the calculation of excel sheet data , the market share of NIRLIFE HC is found to be

37.5 % in iv set in retail stores.

From the calculation of excel sheet data , the market share of NIRLIFE HC is found to be

13 % in diaper in retail stores.

48

TABLE-5.3.1.1

PATHOLOGY LAB

Name of PL Place S/N Sales

Bhagyoday Bapunagar NL >60

Shreeji Bapunagar NL 41-60

Astha Bapunagar BD 21-40

Kacchadiya Bapunagar NL 20<

Radhe Bapunagar NL >60

Divine Bapunagar BD 41-60

Hardik Bapunagar NL 21-40

Adarsh Bapunagar DISPO 20<

Bilani Naroda NL/DISPO 20<

Medi Care Naroda NL 21-40

Milan Naroda NL 41-60

Patel Naroda NL >60

Ronak Naroda TG 20<

Kedar Naroda NL 21-40

Prem Naroda BD 41-60

Ram Naroda NL >60

Bajaj Naroda NL 41-60

Dev Naroda NL 21-40

Gayatri Naroda NL 20<

Sivam Naroda TG >60

Bharat Naroda TG 41-60

Sanjeevani Naroda BD 21-40

Bhagyashri Naroda TG 20<

Dhruti Maninagar NL >60

Dhanvantari Maninagar NL 20<

Shivam Maninagar BD 21-40

Shalam Maninagar NL 41-60

Kashyap Maninagar DISPO >60

Scientific Satellite NL >60

Gold Coin Satellite NL 41-60

49

Reliable Satellite TG 21-40

Sigma Satellite NL 20<

Parsva Jeevandeep Satellite TG >60

Giriraj Satellite TG 41-60

Shradha Satellite NL 20<

Vraj Satellite DISPO/NL >60

Sun Satellite NL 41-60

Symmers Satellite DISPO 21-40

Shubham Satellite NL 20<

Rushabh Satellite NL >60

Suuvidha Satellite NL 41-60

Balaji Satellite DISPO >60

Aarambh Naranpura NL 41-60

Shree Shubham Naranpura DISPO 21-40

Vrundavan Naranpura NL 20<

Shubh Lakshmi Naranpura DISPO >60

Ankur Naranpura BD 21-40

Pathocare Naranpura NL 20<

Astha Thakkerbapanagar NL 20<

Akshar Karishnanagar NL >60

Manan Karishnanagar BD 41-60

Navkar Karishnanagar NL 21-40

Milan Karishnanagar BD 20<

Sivam Karishnanagar BD >60

Bajaj Karishnanagar NL 41-60

Ram Karishnanagar BD 21-40

Sanjivani Vadaj NL 20<

Darpan Vadaj NL >60

Shilp Vadaj NL 41-60

Vadaj Vadaj NL 21-40

Mahakant Vadaj BD 20<

Sarthak Vadaj NL >60

Raj Vadaj NL 21-40

50

Nishant Vadaj NL >60

Mukti Vadaj BD >60

Parth Vadaj BD 41-60

Krishna Vadaj NL 21-40

Sarthak Vadaj NL 20<

Ranip Vadaj NL 41-60

Ganshyam Vadaj BD 20<

Shivam Vadaj NL 41-60

Home Care Vadaj BD 41-60

Satyam Vadaj BD >60

Vrundavan Vadaj NL 41-60

Medicare Diagnostics Vadaj BD 21-40

Calculation:

SYRINGE - NEEDLE

SUM OF LOW HIGH

ALL 2377 2240

NL 1361 1320

     

MARKET SHARE

NL 43.52 44.79

Interpretation:

From the calculation of excel data sheet , the market share of NIRLIFE HC is found to be

44%, in syringe and needle in Pathology lab.

DATA ANALYSIS 3 : 5.4) CHI-SQUARE TEST

5.4.1) Preference and consumption of syringe and needle at retail store

51

TABLE-5.3.2.2

H0 : There is no association between preference of syringe/needle and consumption of

syringe/needle at retail stores .

H1 : There is association between preference of syringe/needle and consumption of syringe/needle

at retail stores.

Syringe/needle*consumption

consumption

Observed N

Expected N

Residual

21-40 26 30.0 -4.0

42-60 31 30.0 1.0

>60 33 30.0 3.0

Total 90

Chi-square test

consumption

Chi-Square .867a

Df 2

Asymp. Sig. .648

Monte Carlo Sig.

Sig. .722b

95% Confidence Interval

Lower Bound

.630

Upper Bound

.815

Interpretation:

52

TABLE-5.4.1.1

TABLE-5.4.1.2

Here significance value is greater than 0.05 so I accept H0 null hypothesis so, There is no

association between preference of syringe/needle and consumption of syringe/needle at retail

stores .

5.4.2) Preference and consumption of IV set at retail stores

H0: There is no association between preference of IV set and consumption of IV set .

H1 : There is association between preference of IV set and consumption of IV set.

IV set *consumption

Consumption

Observed N Expected N Residual

20< 2 22.5 -20.5

21-40 32 22.5 9.5

42-60 29 22.5 6.5

>60 27 22.5 4.5

Total 90

Test Statistics

consumption

53

TABLE-5.4.2.1

TABLE-5.4.1.2

Chi-Square 25.467a

Df 3

Asymp. Sig. .000

Monte Carlo Sig.

Sig. .000b

90% Confidence Interval

Lower Bound

.000

Upper Bound

.025

Interpretation:

Here significance value is less than 0.05 so i reject H0 null hypothesis and accept H1 so, There is

some association between preference of Iv set and consumption of Iv set.

5.4.3) Preference and consumption of Diaper at retail stores

H0: There is no association between preference of Diaper and consumption of Diaper.

H1 : There is association between preference of Diaper and consumption of Diaper.

Diaper*consumption

54

TABLE-5.4.3.1Consumption

Observed N

Expected N

Residual

20< 44 30.0 14.0

21-40 44 30.0 14.0

>60 2 30.0 -28.0

Total 90

Test Statistics

consumption

Chi-Square 39.200a

Df 2

Asymp. Sig. .000

Monte Carlo Sig.

Sig. .000b

90% Confidence Interval

Lower Bound

.000

Upper Bound

.025

Interpretation:

Here significance value is less than 0.05 so I reject H0 null hypothesis and accept H1 so, there is

some association between preference of diaper and consumption of diaper.

5.4.4) Preference and consumption of syringe/Needle at Pathology lab

H0: There is no association between preference of syringe/Needle and consumption of

syringe/Needle at Pathology lab.

H1 : There is association between preference of syringe/Needle and consumption of syringe/Needle

at Pathology lab.

55

TABLE-5.4.3.2

TABLE-5.4.4.1

Syringe/Needle *consumption

consumption

Observed N

Expected N

Residual

20< 18 18.8 -.8

21-40 17 18.8 -1.8

41-60 20 18.8 1.3

>60 20 18.8 1.3

Total 75

Test Statistics

consumption

Chi-Square .360a

Df 3

Asymp. Sig. .948

Monte Carlo Sig.

Sig. .947b

90% Confidence Interval

Lower Bound

.904

Upper Bound

.989

Interpretation:

Here significance value is greater than 0.05 so I accept H0 null hypothesis so, There is no

association between preference of syringe/needle and consumption of syringe/needle at path lab.

56

TABLE-5.4.4.2

CHAPTER 6 : FINDING OF THE STUDY

From conducting this research, I found thet

1) There are large number of syringe and needle used in India. For syringe and needle, there are

two type of market 1) local market, 2) branded market. Around 10-15 % is goes to local market

57

and 85-90 % is goes to Branded market for syringe and needle. Most of syringe and needle are

consumed due to doctor’s preference to the Branded syringe and needle. 2)

2) In Pathology lab syringe and needle used which is more profitable, good in quality and

available in large range of size is preferable.

3) For the IV set, now a day a consumption of Branded is more. For the diaper there is equal

market for both local as well as Branded. There is preference of consumer so that there is large

number of variable affect it. There is large number of companies in diaper manufacturer.

LIMITATION

Although this research project was carefully prepared by me, I am still aware of its limitations and

shortcomings. The research was conducted in the month of May-June, so there is less chance of

diseases compare to monsoon and winter. The respondent (chemist) did not give their response

properly. The time was also a limited constraint for this project because there are so many retail

medical stores are left which cause greater result in this project. It would be better if it was done in

a longer time. So data may vary from time to time.

RECOMMANDATION

I recommend from this project that Nirlife deserve good market share , good repo, good will in the

market. From my this research, I suggest that

58

1) Nirlife’s product is sold due to good margin to retail stores and Pathology lab but they should

increase the quality as BD to increase the sales and to increase the market share. There are so many

retail medical stores are found in which keeps unknown brand of syringe and needle which covered

some profitable market share. They were cheaper in price and give the same result as other branded

creams.

CHAPTER 7 : CONCLUSION

Primary data was collected through questionnaires by asking respondents to rate the variables as

per their preference for syringe/needle, IV set, diaper. From the analysis of data, I conclude that

market presence of Nirlife health care is 33 retail stores out of 90. It seems to be good and market 59

presence of Nirlife health care is 40 path labs out of 75. For IV set market presence is 33 out of 90

and for diaper market presence is 13 out of 90.

From ms-excel calculation, I conclude that market share of syringe and needle is 35.5 %, for IV set

is 37.5 % and for diaper is 13 % in retail stores. For syringe and needle in Pathology lab, Nirlife

cantains 44 % market share.

60

ANNEXURE

Questionnaire For retail stores

(FOR RS, MDD PRODUCTS NIRLIFE, AND MARKET SURVEY)

Drug store Name:

Area:

1. Which company’s syringe and needle you are keeping?

_____________________ And/or___________________.

2. Why are you keeping that syringe and needle ?

______________________________________.

3. Which company’s IVset you are keeping?

_________________and/or________________.

4. Which company’s diapers you are keeping?

_________________and/or________________.

61

I am a student of MBA (pharmaceuticals) at CENTRE FOR MANAGEMENT STUDIES, GANPAT

UNIVERSITY.

The following questionnaire contains some of the objective questions and same is the part of my

research work of the “In-depth study of market share and market presence of MDD product with

reference to Nirlife health care pvt ltd.”

Kindly mark the blanks that best indicates how they would describe the object being rated.

5. What do u think about consumption per month for syringes and needles?

a) Less than 20 b) 21-40

c) 41-60 d) Above 60

6. What do u think about consumption per month for IV set?

a) Less than 20 b) 21-40

c) 41-60 d) Above 60

7. What do u think about consumption per month for diaper?

a) Less than 20 b) 21-40

c) 41-60 d) Above 60

THANK YOU

62

QUESTIONNAIRE FOR PATHLAB

(for pl , mdd products Nirlife , market survey)

NAME:

AREA:

NAME OF PERSON:

1. Which company’s syringe and needle you preffered?

_____________________.

2. Why you preffered that syringe and needle ?

___________________________________________ .

3. What do u think about consumption per month?

a) Less than 20 b) 21-40

c) 41-60 d) Above 60

63

I am a student of MBA (pharmaceuticals) at CENTRE FOR MANAGEMENT STUDIES, GANPAT

UNIVERSITY.

The following questionnaire contains some of the objective questions and same is the part of my

research work of the topic “market share and market presence of MDD product with reference

to Nirlife health care pvt ltd”

Kindly mark the blanks that best indicates how they would describe the object being rated.

4. Which ml and type of syringes you preffered?

Ml_______ and 2 pc

3 pc

5. Which criteria is most important for selection of syringe and needle ?

Service price

Quality margin

THANK YOU

64

BIBLIOG RAPHY

a. Kotler, Armstrong. Principles of Marketing Pearson education, 2011.

b. Malhotra, Dash. Marketing Research, Prentice Hall, 2010.

c. Manav kataria, viral thakar (2010), “B plan retractable and auto disable syringe”, as appeared

in proquest.com/india/market research downloaded on date-20/05/2013

d. Rumana Anjuman Ara,(2012),“ Report On Business Marketing (Course: 514) Topic: Business

Marketing Research on JMI”, a B2B Market, Section: A Department of Marketing (14

th),Faculty of Business Studies , University of Dhaka. Vol. 11 No. 1, pp. 18-28.

e. Nirma Group Limited,Nirlife health care pvt ltd,2008-2013, e-mail:

nirlifehealthcare@nirma.co.in, Nirlifehealthcare.in.

65